Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $33.35 USD
Change Today -0.93 / -2.71%
Volume 1.2M
PODD On Other Exchanges
As of 8:10 PM 03/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Charles T. Liamos

Director of Advanced Technology and Director, Insulet Corporation
AgeTotal Calculated CompensationThis person is connected to 51 board members in 6 different organizations across 9 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Charles T. Liamos, also known as Charlie, serves as a Partner of MedVenture Associates. Mr. Liamos has been Director of Advanced Technology at Insulet Corporation since January 2014. Mr. Liamos served as the Chief Operating Officer of Insulet Corporation from 2010 to January 21, 2014. He joined MedVenture Associates in September 2006 as Executive Residence. He has more than 10 years of experience of finance and operations’ leadership positions and more than 11 years ...

Read Full Background

Corporate Headquarters*

600 Technology Park Drive
Billerica, Massachusetts 01821

United States

Phone: 978-600-7000
Fax: 978-600-0120

Board Members Memberships*

Former Chief Operating Officer, Chief Financial Officer, Principal Accounting Officer, Director, Executive Officer of TheraSense Canada, Executive Officer of TheraSense UK Limited and Executive Officer of TheraSense Sales Corp
Former Director
Director of Advanced Technology and Director


The University of Vermont

Other Affiliations*

Annual Compensation*

Total Annual Compensation$376,885

Stock Options*

Restricted Stock Awards$1,474,200
All Other Compensation$7,650
Exercised Options113,808
Exercised Options Value$2,573,304
Exercisable Options83,037
Exercisable Options Value$1,727,187
Unexercisable Options85,000
Unexercisable Options Value$1,628,700
Total Value of Options$5,929,191
Total Number of Options281,845

Total Compensation*

Total Annual Cash Compensation$563,120
Total Short Term Compensation$376,885
Other Long Term Compensation$1,481,850
Total Calculated Compensation$2,246,566
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PODD:US $33.35 USD -0.93


Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
Philip Bowman Chief Executive Officer and Executive Director
Smiths Group plc
1.5M GBP
Yasuchika Hasegawa Chairman and Chief Executive Officer
Takeda Pharmaceutical Company Limited
Kim D. Blickenstaff Chief Executive Officer, President and Director
Tandem Diabetes Care, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INSULET CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at